Deforolimus
Deforolimus Uses, Dosage, Side Effects, Food Interaction and all others data.
Trade Name | Deforolimus |
Generic | Ridaforolimus |
Ridaforolimus Other Names | Deforolimus, Ridaforolimus |
Type | |
Formula | C53H84NO14P |
Weight | Average: 990.222 Monoisotopic: 989.562943387 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in solid tumors, sarcoma, cancer/tumors (unspecified), endometrial cancer, prostate cancer, and bone metastases.
How Deforolimus works
Deforolimus inhibits the mammalian target of rapamycin (mTOR), a serine kinase of the phosphatidylinositol-3-kinase (PI3K) family that regulates protein synthesis, affecting cell growth and proliferation. mTOR is a downstream effector of the phosphatidylinositol 3-kinase/Akt and nutrient-sensing pathways which cancer cells need to proliferate.
Innovators Monograph
You find simplified version here Deforolimus